Authors:
KASIMIRBAUER S
KLAASSEN U
KADING J
SEEBER S
Citation: S. Kasimirbauer et al., DETECTION OF ISOLATED BREAST-CARCINOMA CELLS IN BONE-MARROW AND STEM-CELL GRAFTS BY IMMUNOMAGNETIC SEPARATION AND IMMUNOCYTOCHEMISTRY, Annals of oncology, 9, 1998, pp. 103-103
Authors:
KASIMIRBAUER S
OTTINGER HD
BELKA C
STELLBERG W
HALFMEYER K
GEWALTIG I
HARSTRICK A
GROSSEWILDE H
SEEBER S
SCHEULEN ME
Citation: S. Kasimirbauer et al., ANALYSIS OF THE RELATIONSHIP OF P53 STATUS AND RESISTANCE TO CHEMOTHERAPY IN CANCER CELL-LINES AS EVALUATED BY LUMINOMETRIC IMMUNOASSAY (LIA), Tumordiagnostik & Therapie, 19(4), 1998, pp. 113-118
Authors:
KASIMIRBAUER S
OTTINGER H
MEUSERS P
BEELEN DW
BRITTINGER G
SEEBER S
SCHEULEN ME
Citation: S. Kasimirbauer et al., IN ACUTE MYELOID-LEUKEMIA, COEXPRESSION OF AT LEAST 2 PROTEINS, INCLUDING P-GLYCOPROTEIN, THE MULTIDRUG RESISTANCE-RELATED PROTEIN, BCL-2, MUTANT P53, AND HEAT-SHOCK-PROTEIN-27, IS PREDICTIVE OF THE RESPONSE TO INDUCTION CHEMOTHERAPY, Experimental hematology, 26(12), 1998, pp. 1111-1117
Authors:
KASIMIRBAUER S
OTTINGER H
WUTTKE M
STELLBERG W
GROSSEWILDE H
SEEBER S
SCHEULEN ME
Citation: S. Kasimirbauer et al., CHRONIC MYELOGENOUS LEUKEMIA - EFFECT OF INTERFERON-ALPHA TREATMENT ON PHAGOCYTIC-ACTIVITY AND CAPACITY OF CIRCULATING NEUTROPHILS, Leukemia research, 22(2), 1998, pp. 115-117
Citation: M. Stahl et al., DOWN-REGULATION OF TOPOISOMERASE-II BY CAMPTOTHECIN DOES NOT PREVENT ADDITIVE ACTIVITY OF THE TOPOISOMERASE-II INHIBITOR ETOPOSIDE IN-VITRO, Anti-cancer drugs, 8(7), 1997, pp. 671-676
Authors:
OTTINGER HD
BEELEN DW
KASIMIRBAUER S
SCHULTEWOLTER T
REBMANN V
GOOS M
SCHEULEN ME
SEEBER S
SCHAEFER UW
GROSSEWILDE H
KLOKE O
Citation: Hd. Ottinger et al., GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) REDUCES THE CAPACITY OFT-CELLS TO EXPRESS PRO-INFLAMMATORY CYTOKINES AND INCREASES SOLUBLE HLA PLASMA-LEVELS IN HUMANS, Blood, 90(10), 1997, pp. 423-423
Authors:
SCHRODER J
ESTEBAN M
MULLER MR
KASIMIRBAUER S
BAMBERGER U
HECKEL A
SEEBER S
SCHEULEN ME
Citation: J. Schroder et al., MODULATION OF MULTIDRUG-RESISTANCE BY BIBW22BS IN BLASTS OF DE-NOVO OR RELAPSED OR PERSISTENT ACUTE MYELOID-LEUKEMIA EX-VIVO, Journal of cancer research and clinical oncology, 122(5), 1996, pp. 307-312
Authors:
KASIMIRBAUER S
OTTINGER H
BRITTINGER G
KONIG W
Citation: S. Kasimirbauer et al., PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA - FUNCTIONAL DEFECTS IN CIRCULATING MATURE NEUTROPHILS OF UNTREATED AND INTERFERON-ALPHA-TREATED PATIENTS, Experimental hematology, 22(5), 1994, pp. 426-431
Authors:
KASIMIRBAUER S
OTTINGER H
BRITTINGER G
KONIG W
Citation: S. Kasimirbauer et al., INCREASED FUNCTION OF NEUTROPHILS FROM PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) AFTER PRIMING WITH G-CSF, GM-CSF AND TNF-ALPHA, The Journal of immunology, 150(8), 1993, pp. 201-201